[This review was originally posted at the Nieman Journalism Lab Bactrim For Sale, on April 1, 2011.]
Putting the Times' pay plan in place: If you read last week's review, the first half of this week's should feel like déjà vu — lots of back-and-forth about the wisdom of The New York Times' new online pay plan, and some more hand-wringing about getting around that plan. If you want to skip that and get to the best stuff, I recommend Staci Kramer, David Cohn, and Megan Garber.
The Times launched its pay system Monday with a letter to its readers (snarkier version courtesy of Danny Sullivan), along with a 99-cent trial offer for the first four weeks and free access for people who subscribe to the Times on Kindle, Bactrim price. Times digital chief Martin Nisenholtz gave a launch-day talk to newspaper execs, highlighted by his assertion that the link economy is not a win-win for content producers and aggregators.
Meanwhile, the discussion about the paywall's worth rolled on. You can find a good cross-section of opinions in this On Point conversation with Ken Doctor, the Journal Register's John Paton, The Times' David Carr, and NYTClean creator David Hayes, Bactrim For Sale. The plan continues to draw support from some corners, Get Bactrim, including The Onion (in its typically ironic style, of course) and PC Magazine's Lance Ulanoff. Former Financial Times reporter Tom Foremski and Advertising Age columnist Simon Dumenco both made similar arguments about the value of the plan, where can i buy cheapest Bactrim online, with Foremski urging us to support the Times as a moral duty to quality journalism and Dumenco ripping the blogosphere's paywall-bashers for not doing original reporting like the Times.
And though the opposition was expressed much more strongly the past two weeks, there was a smattering of dissent about the plan this week, too — some from the Times' mobile users. One theme among the criticism was the cost of developing the plan: Philip Greenspun wondered how the heck the Times spent $40 million on planning and implementation, and former Guardian digital head Emily Bell wrote about the opportunity cost of that kind of investment. Rx free Bactrim, BNET's Erik Sherman proposed that the Times should have invested the money in innovation instead.
A few other interesting thoughts about the Times' pay plan before we get to the wall-jumping debate: Media consultant Judy Sims said the plan might actually make the Times more social Bactrim For Sale, by providing an incentive for subscribers to share articles on social networks to their non-subscribing friends. Spot.Us' David Cohn argued that the plan is much closer to a donation model than a paywall and argued for the Times to offer membership incentives. And Reuters' Felix Salmon talked about how the proposal is changing blogging at the Times.
PaidContent's Staci Kramer said the Times is fighting an uphill battle in the realm of public perception, but that struggle is the Times' own fault, created by its way-too-complicated pay system.
—
The ethics of paywall jumping: With the Times' "pay fence" going into effect, Bactrim pictures, all the talk about ways to get around that fence turned into a practical reality. Business Insider compiled seven of the methods that have been suggested: A browser extension, Twitter feeds, using different computers, NYTClean and a User Script's coding magic, Google (for five articles a day), and browser-switching or cookie-deleting, Bactrim For Sale. Mashable came up with an even simpler one: delete "?gwh=numbers" from the Times page's URL.
Despite such easy workarounds, the Times is still cracking down in other areas: As Search Engine Land's Danny Sullivan noted, it blocks links from all Google sites after the five-articles-per-day limit is reached. Bactrim price, coupon, The Times also quickly (and successfully) requested a shutdown of one of the more brazen free-riding schemes yet concocted — NYT for a Nickel, which charged to access Times articles without paywall restrictions. (It did, however, let up on unauthorized Twitter aggregators of Times content.)
So we all obviously can crawl through the Times' loopholes, but should we. A few folks made efforts to hack through the ethical thicket of the Times' intentional and unintentional loopholes: Times media critic James Poniewozik didn't come down anywhere solid Bactrim For Sale, , but said the Times' leaky strategy "makes the paywall something like a glorified tip jar, on a massive scale—something you choose to contribute to without compulsion because it is the right thing" — except unlike those enterprises, it's for-profit. In a more philosophical take, the Lab's Megan Garber said the ethical conundrum shows the difficulty of trying to graft the physical world's ethical assumptions onto the digital world.
—
A possible +1 for publishers: Google made a big step in the direction of socially driven search this week with the introduction of +1, purchase Bactrim online, a new feature that allows users to vote up certain search results in actions that are visible to their social network. Here are two good explainers of the feature from TechCrunch and Search Engine Land, both of whom note that +1's gold mine is in allowing Google to personalize ads more closely, and that it's starting on search results and eventually moving to sites across the web.
The feature was immediately compared to Facebook's "Like" and Twitter's retweets, Bactrim no rx, though it functions a bit differently from either. As GigaOM's Mathew Ingram noted, because it's Google, it's intrinsically tied to search, which is both an advantage and a disadvantage. As Ingram said, it's smart to add more of a social component to search, but Google's search-centricity makes the "social network" aspect of +1 awkward, just as Buzz and Wave were, Bactrim For Sale. To paraphrase the argument of Frederic Lardinois of NewsGrange: if your +1's go into your Google Profile and no one sees them, do they really make a sound, generic Bactrim.
All this seems to be good news for media sites. Lost Remote's Cory Bergman said that if they essentially become "improve the SEO of this site" buttons, media companies will be pretty motivated to add them to their sites. Likewise, Poynter's Damon Kiesow reasoned that +1 could be a great way for media sites to more deeply involve visitors who arrive via Google, Bactrim duration, who have typically been less engaged than visitors from Facebook and Twitter.
—
Shrinking innovation to spur it: This month's Carnival of Journalism Bactrim For Sale, focuses on how to drive innovation, specifically through the Knight News Challenge and Reynolds Journalism Institute. Most of the posts rolled in yesterday, and they contain a litany of quick, smart ideas of new directions for news innovation and how to encourage it.
A quick sampling: City University London and Birmingham City University j-prof Paul Bradshaw proposed a much broader, smaller-scale News Challenge fund, with a second fund aimed at making those initiatives scale, where can i buy Bactrim online. J-Lab Jan Schaffer said we need to quit looking at innovation so much solely in terms of tools and more in terms of processes and relationships. British journalist Mary Hamilton and Drury j-prof Jonathan Groves both focused on innovation in training, with Groves proposing "innovation change agents" funded by groups like Knight and the RJI to train and transform newsrooms.
Also, University of British Columbia j-prof Alfred Hermida opined on the role of theory in innovation, Lisa Williams of Placeblogger advocated a small-scale approach to innovation, and the University of Colorado's Steve Outing had some suggestions for the RJI fellowship program, Bactrim For Sale.
—
The mechanics of Twitter's information flow: Four researchers from Yahoo and Cornell released a study this week analyzing, as they called it, Buy Bactrim no prescription, "who says what to whom on Twitter." One of their major findings was that half the information consumed on Twitter comes from a group of 20,000 "elite" users — media companies, celebrities, organizations and bloggers. As Mathew Ingram of GigaOM observed, that indicates that the power law that governs the blogosphere is also in effect on Twitter, and big brands are still important even on a user-directed platform, Bactrim no prescription.
The Lab's Megan Garber noted a few other interesting implications of the study, delving into Twitter's two-step flow from media to a layer of influential sources to the masses, as well as the social media longevity of multimedia and list-oriented articles. A couple of other research-oriented items about Twitter: A Lab post on Dan Zarrella's data regarding timing and Twitter posts, and Maryland prof Zeynep Tufekci wrote a more theoretical post on NPR's Andy Carvin and the process of news production on Twitter.
—
Reading roundup: Plenty of other bits and pieces around the future-of-news world this week:
— New York Times editor Bill Keller wrote a second column Bactrim For Sale, , and like his anti-aggregation piece a couple of weeks ago, this piece — about the value of the Times' impartiality and fact-based reporting — didn't go over well. Buy Bactrim without prescription, Reuters' Felix Salmon called him intellectually dishonest, Scott Rosenberg called him defensive, and the Huffington Post's Peter Goodman (a former Times reporter) said Keller misrepresented him.
— A few notes on The Daily: Forbes' Jeff Bercovici said it was downloaded 500,000 times during its trial period and has 70,000 regular users, and a study was conducted finding that it's more popular with less tech-savvy, purchase Bactrim for sale, less content-concerned users.
— Journal Register Co. CEO John Paton talked about transforming newspapers at the Newspaper Association of America convention; he summarized what he had to say in 10 tweets, and Alan Mutter wrote a post about the panel. The moderator, Ken Doctor, wrote a Lab post looking at how long newspapers have left.
— I'll send you off with Jonathan Stray's thoughtful post on rethinking journalism as a system for informing people, rather than just a series of stories. It's a lot to chew on, but a key piece to add to the future-of-news puzzle.
Similar posts: Buy Tramadol No Prescription. Order Flagyl. Tramadol Over The Counter. Purchase Armour. Cheap Retin A no rx. Purchase Glucophage for sale.
Trackbacks from: Bactrim For Sale. Bactrim For Sale. Bactrim For Sale. Bactrim dosage. Ordering Bactrim online. Buy cheap Bactrim no rx.
[This review was originally posted at the Nieman Journalism Lab Synthroid Cost, on March 25, 2011.]
Debating the Times’ pricing structure: There was really only one big news story in the media world this week: The New York Times’ paid-content plan, which is live in Canada now and coming to everyone else on Monday. I divided the issue into two sections — the first on general commentary on the plan, and the second specifically about efforts to get around the paywall.
We learned a bit more about the Times’ thinking behind the plan, with a story in the Times about the road from its last paid-content system, TimesSelect, to this one, Synthroid treatment, and an All Things Digital interview with Times digital chief Martin Nisenholtz, in which he said, among other things, that the Times didn’t consider print prices when setting their online price levels. Order Synthroid no prescription, Former Times designer Khoi Vinh also looked at the last couple of years, lamenting the lost opportunity for innovation and the legacy of TimesSelect.
There were a couple of pieces written supporting the Times’ proposal: Former CBS digital head Larry Kramer said he’d be more likely to pay for the Times than for the tablet publication The Daily, even though it’s far more expensive. The reason. The Times’ content has consistently proven to be valuable over the years. (Tech blogger John Gruber also said the Times’ content is much more valuable than The Daily’s, but wondered if it was really worth more than five times more money.) Nate Silver of Times blog FiveThirtyEight used some data to argue for the Times’ value.
The Times’ own David Carr offered the most full-throated defense of the pay plan, arguing that most of the objection to it is based on the “theology” of open networks and the free flow of information, rather than the practical concerns involved with running a news organization, Synthroid Cost. Reuters’ Felix Salmon countered that the Times has its own theology — that news orgs should charge for content because they can, Synthroid mg, and that it will ensure their success. Later, though, Salmon ran a few numbers and posited that the paywall could be a success if everything breaks right.
There were more objections voiced, Synthroid dosage, too: Both Mathew Ingram of GigaOM and former newspaper journalist Janet Coats both called it backward-looking, with Ingram saying it “seems fundamentally reactionary, and displays a disappointing lack of imagination.” TechDirt’s Mike Masnick ripped the idea that people might have felt guilty about getting the Times for free online.
One of the biggest complaints revolved around the Times’ pricing system itself, which French media analyst Frederic Filloux described as “expensive, utterly complicated, disconnected from the reality and designed to be bypassed.” Others, Synthroid samples, including Ken Doctor, venture capitalist Jean-Louis Gassee, and John Gruber, made similar points about the proposal’s complexity, Synthroid recreational, and Michael DeGusta said the prices are just too high. Poynter’s Damon Kiesow disagreed about the plan structure, arguing that it’s well-designed as an attack on Apple’s mobile paid-content dominance.
—
Are paywall loopholes a bug or feature?: Of course, any barrier online is also a giant, flashing invitation to get around said barrier, and someplace as influential as the Times was not going to be an exception, online Synthroid without a prescription. Several ways to bypass the Times’ pay system popped up in the last week: There was @FreeNYT, the Twitter account that will aggregate Times content shared on Twitter, and NYTClean, a browser bookmarklet that strips the Times’ paywall coding, allowing you to read the Times just like normal. The Lab’s Josh Benton noted how easy the hack was to come up with (four lines of code!) and speculated that Synthroid Cost, the Times might actually want nerds to game their system, “because they (a) are unlikely to pay, (b) generate ad revenue, and (c) are more likely to share your content than most.”
So how has the Times responded to all this. A bit schizophrenically. Publisher Arthur Sulzberger Jr, buy no prescription Synthroid online. said the people who would find ways around the system would be “mostly high-school kids and people who are out of work.” And the Times asked Twitter to shut down the aggregating Twitter accounts (for a trademark violation) and extended its limit on daily search-engine referrals beyond Google. But the Times is also widening some pathways of its own, making it so you can’t hit the wall directly from a blog link, and offering 200, Synthroid australia, uk, us, usa, 000 regular readers free online access for the rest of the year through an advertiser.
Search Engine Land’s Danny Sullivan mocked the Times’ behavior toward wall-jumpers as an effort to have its paid-content cake and eat it too: “This wall is designed, as best I can tell, only to be a barrier to your most loyal — and most stupid — readers.” Slate’s Jack Shafer made a similar argument to Benton’s, pointing out that online free-riders aren’t keeping paying customers from reading the Times (like, say, someone who steals a paper edition, Synthroid trusted pharmacy reviews, as Sulzberger analogized) and are actually help the paper continue its influence and reach.
—
Adding community to local data: EveryBlock, a three-year-old site owned by MSNBC.com that specializes in hyperlocal news data, unveiled its first major redesign this week, which includes a shift in focus toward community and location-based conversation, Synthroid coupon, rather than just data. All place pages now allow users to post messages to those nearby, using what founder Adrian Holovaty called the “geo graph,” rather than the “social graph.” Mashable added a few valuable details (notably, the site will bring in revenue from location-based Groupon displays and Google ads).
Holovaty answered a lot of questions about the redesign in a Poynter chat, saying that the site’s mission has changed from making people informed about their area as an end in itself to facilitating communication between neighbors in order to improve their communities, Synthroid Cost. GigaOM’s Mathew Ingram applauded the shift in thinking, arguing that the main value in local news sites is in the people they connect, not in the data they collect. At 10,000 Words, comprar en línea Synthroid, comprar Synthroid baratos, Jessica Roy noted that the change was a signal that hyperlocal sites should focus not just on the online realm, but on fostering offline connections as well.
—
NPR on the defensive: Two weeks on, the hidden-camera attack on NPR continues to keep it in the middle of the news conversation. Following last week’s vote by the House to cut off NPR’s limited federal funding, Synthroid canada, mexico, india, several media folks made cases to keep NPR’s federal funding alive, including the Washington Post’s Len Downie and Robert Kaiser and Poynter’s Roy Peter Clark. NPR host Steve Inskeep argued that NPR’s most important work has nothing to do with any liberal/conservative bias. “Think again of my colleagues in Libya, going forward to bear witness amid exploding shells. Is that liberal or conservative?” he asked.
Synthroid Cost, Elsewhere, James O’Keefe, the producer of the gotcha video, and Bob Garfield of NPR’s On The Media had it out on the air, and DailyFinance gave a picture of NPR’s financial situation. Howard Kurtz of Newsweek and The Daily Beast wrote that some NPR journalists think that NPR management’s passive, reactionary defense of their organization is damaging it almost as much as the attacks themselves.
—
Reading roundup: Not too busy of a week in the media world outside of Timesmania, Synthroid without a prescription. A few things to take note of:
— A quick news item: Journalism Online, Steve Brill’s initiative to help media companies charge for their content online, is being snatched up by the Fortune 500 printer RR Donnelley, reportedly for at least $35 million. PaidContent broke the story, and Ken Doctor wrote about the unexpected difficulties the startup encountered.
— At the New York Review of Books, Steve Coll wrote a thoughtful piece on the competing claims regarding technology’s role in social change.
— For the stat nerds: The Lab’s Josh Benton looked at the latest of the continual stream of depressing graphs flowing from the newspaper industry, and Peter Kafka of All Things Digital analyzed the source of traffic for some major sites across the web, comparing the influence of Facebook and Google.
— For the academic nerds: Here at the Lab, USC Ph.D. candidate Nikki Usher talked to media sociology rock star Herbert Gans about targeted and multiperspectival news, and Michigan Ph.D. candidates William Youmans and Katie Brown shared a fascinating study about Al Jazeera and bias perception.
.Similar posts: Retin A Price. Order Lipitor. Synthroid Over The Counter. Synthroid no rx. Buy Retin A no prescription. Diflucan from canada.
Trackbacks from: Synthroid Cost. Synthroid Cost. Synthroid Cost. Buy Synthroid without a prescription. Synthroid no prescription. Synthroid long term.
[This review was originally posted at the Nieman Journalism Lab Purchase Lipitor, on March 18, 2011.]
First reactions to The Times' paid-content plans: Yesterday The New York Times rolled out the online paid-content plans they've been talking about for a little more than a year. You get 20 articles a month for free (besides the ones you get to through Google and social media), and after that it's going to cost you anywhere from $15 to $35 per four weeks, depending on what devices you want to access it on. Print subscribers will get it all for free. (Yup, as the Lab's Josh Benton and Forbes' Jeff Bercovici pointed out, that means there are print plans with online access that are cheaper than the online-only ones.) Subscriptions will sold, Lipitor results, among other places, in Apple's iTunes store. Here's The Times' letter to readers and news article, as well as the Lab's glimpse at the paywall and a good paidContent FAQ.
Now for the reaction and analysis: If you only have time for a few pieces, make them Ken Doctor, Steve Outing, and Felix Salmon, Purchase Lipitor. If you want a quick sampler platter of opinions, you can't do any better than the Lab's roundup of 11 experts' thoughts.
There was no consensus of initial opinion about the plan; many supporters spoke up quickly, including The Times' own media critic, David Carr, purchase Lipitor, and The Daily Beast's Howard Kurtz. Poynter newspaper analyst Rick Edmonds broke down the ways it met all the initial criteria of a sound paywall plan, and British j-prof Paul Bradshaw called it "the most mature, intelligent, and commercially sensible paywall model yet," praising its respect for distribution and online engagement. At The Columbia Journalism Review, Lipitor over the counter, Ryan Chittum said it looked good, and Lauren Kirchner issued a rejoinder to the "information wants to be free" crowd. Purchase Lipitor, The Times' detractors were quick to speak up, too. Media analyst Steve Outing laid out most of the basic objections: The prices are too high, people will turn away when they hit the 20-article limit, and the differentiation by device doesn't make sense. (TechCrunch's Erick Schonfeld harped on the latter point, too.) Reuters' Felix Salmon chimed in by saying that the price point is high enough that a lot of regular readers won't subscribe (meaning the plan won't bring in much revenue anyway), and that the Times is discouraging use of its iPad.
At BoingBoing, Lipitor forum, Cory Doctorow said most users will find the metering system frustrating, leading them to find other ways to read The Times or just not read it at all. Techdirt's Mike Masnick made a similar point, adding that The Times isn't adding any value with the plan. That was tech pioneer Dave Winer's main beef: "They're not offering anything to readers other than the Times' survival, and they're not even explicit about that."
Plenty of commentary didn't fall into either the "pro" or "con" camp, of course, Purchase Lipitor. Here at the Lab, Ken Doctor provided the definitive economic analysis of the plan, breaking down the seven tests it must pass to be successful. Discount Lipitor, Then there was the issue of getting around the paywall (or, as Doctor more accurately called it, the fence): Business Insider told us how to do it via Google, and TechCrunch pontificated on the social media loophole that will develop in addition to the current Google one. Media consultant Steve Yelvington downplayed that factor: "It's not supposed to be a bank vault, people. It's a polite request for payment."
Another obvious next question is whether this could be applied to other news organizations. Purchase Lipitor, Meranda Watling of 10,000 Words compared the plan with those of The Wall Street Journal and Newsday, but Amy Gahran of the Knight Digital Media Center gave other newspapers a stern "don't try this at home."
—
Breaking down an old debate at SXSW: Just as they do every March, geeks descended on Austin, Texas, last weekend for the South by Southwest Interactive Festival, and as usual, there was plenty of journalism-related stuff to chew on, even for those of us who didn't attend. The session that seemed to get the most traction online was NYU professor Jay Rosen's psychological analysis of the tension between bloggers and journalists — which is perhaps a bit surprising for a battle that Rosen himself declared "over" six years ago.
Rosen's whole talk is worth a read, online buy Lipitor without a prescription, but here's the gist of it: For journalists, bloggers are the idealized face of all the ideological and professional stresses they deal with, and for bloggers, the conflict helps keep them on the "outside" of the system, allowing them to maintain their innocence and rhetorical power. Snarkmarket's Matt Thompson and Tim Carmody liveblogged their analysis of the talk, and The Guardian summarized it. Lipitor pics, Michele McLellan of the Knight Digital Media Center ripped blogger-hating journalists for fighting an outdated war, but Melissa Bell of the Washington Post called Rosen's characterization of objectivity misleading.
There were plenty of other panels worth reading about, too, including NYU prof Clay Shirky's timely talk on social media and revolution, in which he said that governments routinely overestimate our access to information and underestimate our access to each other, Purchase Lipitor. (The Guardian had a short summary, and Poynter's Julie Moos put together a blow-by-blow in Storify.)
There were also a couple of panels on the value of gaming, particularly in news, as well as sessions on building trust online, using social media to evade censorship, the future of public media, iPad news apps, is Lipitor safe, and SEO tips from Google and Bing. Poynter's Steve Myers pulled together a dozen journalists for an overview of the conference in terms of building community, and an Economist blogger tied this year's SXSW to last year's with a sharp post questioning the story as the basic unit of journalism.
—
A critical eye on NPR's antagonists: The damage to NPR from James O'Keefe's hidden-camera exposé was already done last week, but the scrutiny of the tape itself didn't begin in earnest until the weekend — kicked off by, of all places, Glenn Beck's website, Lipitor from canada, The Blaze. (Time's James Poniewozik's breakdown is also worth a read.) The site's skepticism of the video's editing was picked up by NPR media reporter David Folkenflik, who examined the issue in a broadcast report. NPR's spokeswoman called the video Purchase Lipitor, "inappropriately edited," but said the executive in the tape had still made "egregious statements."
Whatever O'Keefe's ethics, Poynter's Steve Myers said, there's plenty he understands about today's media environment that we can learn from: Investigative journalism is in demand, raw media communicates "reality," and soundbites and reducing opponents' logic to absurdities trump context in the online media world.
The change in leadership at NPR prompted others to look at the health and direction of the organization overall: The New York Times' David Carr examined NPR's success in light of the public-funding argument, and Poynter's Mallary Jean Tenore laid out the four biggest challenges for NPR's next CEO. The Lab's Nikki Usher looked overseas for public media comparisons, and The Columbia Journalism Review talked to Jonathan Holmes of the Australian Broadcasting Corporation about the public media situation there.
—
A snapshot of the state of journalism: Pew's Project for Excellence in Journalism released its annual State of the Media report this week, summarizing last year as a good one for journalism. The big headline that most media outlets took away from the study was that for the first time, online news consumption has surpassed newspaper use. There were plenty of other nuggets from the study, though, covering a variety of news media.
The study outlined the state of the newspaper industry, touching on all the major themes from circulation to advertising to digital paid-content efforts, Purchase Lipitor. One of the authors of that part of the study, Poynter's Rick Edmonds, Lipitor overnight, summarized the trends he found interesting.
It also included a look at the economics of startup community journalism, with discussion of nonprofits, ad-based sites, and the Patch model. (Author Michele McLellan summarized her main points here.) The researchers also reported on a survey on mobile news use, and Amy Gahran of the Knight Digital Media Center and Damon Kiesow of Poynter highlighted some of the opportunities for news organizations in its results.
A couple of other tidbits from the study: Search Engine Land's Vanessa Fox focused on revenue from advertising, subscriptions, Lipitor alternatives, and mobile apps, and j-prof Alfred Hermida pointed out the difference between the news agendas of Twitter, blogs and the mainstream media.
—
Twitter tells developers to hold off: Twitter made waves in the tech world late last week when they posted a note Purchase Lipitor, telling developers not to develop any more Twitter clients, saying they'd like to do it themselves, ostensibly for consistency's sake. (Mashable has a great explanation of the issue.) Most of the initial reaction was not enthusiastic: Salon's Dan Gillmor said the note was a reminder that we need other options for our online platforms that aren't controlled by a single company, and Dave Winer said it reinforces the fact the open web is the best place to develop.
Mathew Ingram of GigaOM and developer Fred Oliveira both urged Twitter to rethink its decision, noting that third-party apps like Tweetdeck and Tweetie spurred much of Twitter's initial growth. Lipitor without prescription, And ReadWriteWeb's Marshall Kirkpatrick saw this as a hint at where Twitter is headed culturally: "If you thought Twitter was a place for outlaws, for free thinkers, for innovators - you need to tuck in your shirt, cut your hair and get a clue."
Others, however, defended Twitter: Social media marketer Jesse Stay said he wishes Twitter had done this a while ago, and developer Rob Diana argued that Twitter has finally given developers a solid sense of direction while still giving them some freedom.
—
Reading roundup: A few notes to digest while your bracket goes up in flames:
— The big news story of the past week has been the earthquake, tsunami and their aftermath in Japan, Lipitor online cod. There wasn't a whole lot written about it from a media perspective, but there were a couple of insightful posts, Purchase Lipitor. Doc Searls looked at coverage and concluded that the web is subsuming TV and radio, and Jeff Jarvis asked for separate Twitter hashtags for breaking news event witnesses.
— A few leftover AOL/Huffington Post items: GigaOM's Mathew Ingram looked at why AOL is desperate for some successful content initiatives, Arianna Huffington talked SEO, TechCrunch broke down the journalism/churnalism tension at AOL, and The New York Times' Bill Keller issued a non-apology followup to his Huffington-bashing essay last week.
— A couple of stray items from the commenting discussion of the last couple of weeks: Via O'Reilly Radar, Effects of Lipitor, statistics showing the integration of Facebook Comments led to fewer comments at TechCrunch, and a defense of anonymous commenting from Paul O'Flaherty.
— Finally, the Lab has the transcript of an interesting talk Northwestern prof Pablo Boczkowski gave about the gap between what news consumers want and what they get, with a thoughtful response from the Lab's Josh Benton. Enjoy.
Similar posts: Diflucan Cost. Diflucan For Sale. Armour Price. Cipro alternatives. Armour blogs. Diflucan duration.
Trackbacks from: Purchase Lipitor. Purchase Lipitor. Purchase Lipitor. Lipitor results. Lipitor street price. Generic Lipitor.